THERAPEUTIC EQUIVALENCE OF GALAXIA(R) (A NEW FORMULATION OF GENERIC LATANOPROST) VS XALATAN(R): THE RESULTS OF A MULTICENTER RANDOMIZED CLINICAL TRIAL